Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan.
Microbiology Research Division, Kojin Bio Co., Ltd., Saitama, Japan.
Diagn Microbiol Infect Dis. 2019 Dec;95(4):114882. doi: 10.1016/j.diagmicrobio.2019.114882. Epub 2019 Aug 7.
CRE-JU is a novel selective agar for carbapenem-resistant Enterobacteriaceae that contains ceftazidime, cloxacillin, meropenem, and vancomycin. This study evaluated the ability of 63 carbapenem-resistant isolates and 53 non-carbapenem-resistant Enterobacteriaceae strains clinically isolated in Japan, Myanmar, Nepal, and Vietnam to grow on CRE-JU. CRE-JU showed 92.1% sensitivity and 100% specificity for detecting carbapenem-resistant Enterobacteriaceae compared with dug susceptibility profiles.
CRE-JU 是一种新型的耐碳青霉烯类肠杆菌科选择性琼脂,含有头孢他啶、氯唑西林、美罗培南和万古霉素。本研究评估了在日本、缅甸、尼泊尔和越南临床分离的 63 株耐碳青霉烯类肠杆菌科和 53 株非耐碳青霉烯类肠杆菌科菌株在 CRE-JU 上的生长能力。与药敏谱相比,CRE-JU 检测耐碳青霉烯类肠杆菌科的敏感性为 92.1%,特异性为 100%。